COVID-19 with Multiple Bacterial Co-infections: A Case Report


  •   Sadia Saber

  •   Samia Rashna Ahmed

  •   Naz Yasmin

  •   Mohammed Tarek Alam

  •   Abdul Basit Ibne Momen

  •   Mohammad Monower Hossain

  •   Rafa Faaria Alam


Coronavirus disease 2019 (COVID-19) is a contagious disease which was first identified in Wuhan, China in December 2019. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for this ongoing pandemic worldwide. COVID-19 itself has a high mortality rate but in addition with bacterial co-infection, the risk of death amplifies much higher. The diagnosis of COVID-19 along with other respiratory co-infections can be a difficult task due to the similarities in their presentations. Here, we present a case of 60-years-old gentleman who was COVID-19 positive, co-infected with three types of bacterial pathogens, which were Mycobacterium tuberculosis, Enterobacter spp. and Pseudomonas. The patient was isolated and treated according to the pathogens’ culture sensitivity reports and was discharged when his condition improved and advised for routine follow-up. The source of the co-infection could not be identified and may have been hospital acquired. Therefore, every hospital should give utmost priority to infection prevention and control (IPC) strategies.

Keywords: COVID-19, Enterobacter, Pseudomonas, SARS-CoV-2


World Health Organization, "Covid-19 Situation Report: 192," 30 July 2020. [Online]. Available:

Yang X, Yu Y, Xu J, Shu H (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet. Available:

Cui J, Li F, Shi ZL. (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 17(3):181-192. doi:10.1038/s41579-018-0118-9.

World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. Geneva: World Health Organization; 2014 Available from:

Ong SW, Tan YK, Chia PY, Lee TH, Ng OT, Wong MS, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020 Mar 4 [Epub ahead of print].

Zhang Y, Chen C, Zhu S et al. [Isolation of 2019-nCoV from a stool specimen of a laboratory-confirmed case of the coronavirus disease 2019 (COVID-19)]. China CDC Weekly. 2020;2(8):123–4. (In Chinese).

J. F.-W. Chan, S. Yuan, K.-H. Kok, K. K.-W. To, H. Chu and J. Yang, "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. [Online]. Available:

Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40(5):1487-1498. doi:10.1097/CCM.0b013e3182416f23

J. Cohen, W. Powderly and S. Opal, Infectious Disease (Fourth Edition), Elsevier, 2016.

Patel, J. A., Nielsen, F., Badiani, A. A., Assi, S., Unadkat, V. A., Patel, B., Ravindrane, R., & Wardle, H. (2020). Poverty, inequality and COVID-19: the forgotten vulnerable. Public health, 183, 110–111.

World Health Organization, Laboratory testing for coronavirus disease, March 2020.

Nakiyingi, L., Nankabirwa, H., & Lamorde, M. (2013). Tuberculosis diagnosis in resource-limited settings: Clinical use of GeneXpert in the diagnosis of smear-negative PTB: a case report. African health sciences, 13(2), 522–524.

Abong, J., Dalay, V., Langley, I., Tomeny, E., Marcelo, D., Mendoza, V., Aquino, A. C., Garfin, A., Squire, B., & Yu, C. (2019). Use of GeneXpert and the role of an expert panel in improving clinical diagnosis of smear-negative tuberculosis cases. PloS one, 14(12), e0227093.

K. C. C. J. B. a. S. M. Geo. Brooks, Jawetz, Melnick & Adelbergs Medical Microbiology, Lange.

Karnad, A., Alvarez, S., & Berk, S. L. (1987). Enterobacter pneumonia. Southern medical journal, 80(5), 601–604.

M. V. Villegas and J. P. Quinn, "Enterobacter species," [Online] Available:,meningitis%20(4%2C%2039).

Dwivedi, M; Mishra, A; Singh, RK; Azim, A; Baronia, AK; Prasad, KN (2009). Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit. Indian Journal of Pathology and Microbiology.

World Health Organization, "Hospital Hygiene & Infection Control," [Online]. Available:

R. TM, M. LSP, Z. N, R. N, S. K, G. M, S. G, C. G and H. A. (2020). Bacterial and Fungal Coinfection in Individuals with Coronavirus: A Rapid Review to Support COVID-19 Antimicrobial Prescribing. [Online]. Available:

Chih-Cheng Lai, Cheng-Yi Wang, Po-Ren Hsueh. (2020) Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents. Journal of Microbiology, Immunology and Infection. ISSN 1684-1182.

Singhal T. (2020). A Review of Coronavirus Disease-2019 (COVID-19). Indian journal of pediatrics, 87(4), 281–286.

Cox MJ; Loman N; Bogaert D; O'Grady J. (2020) Co-infections: potentially lethal and unexplored in COVID-19. The Lancet.


Download data is not yet available.


How to Cite
Saber, S., Ahmed, S. R., Yasmin, N., Alam, M. T., Ibne Momen, A. B., Hossain, M. M., & Alam, R. F. (2021). COVID-19 with Multiple Bacterial Co-infections: A Case Report. European Journal of Medical and Health Sciences, 3(1), 1–4.

Most read articles by the same author(s)